{"schema_version":"secwatch.filing_event.v1","accession":"0001022079-24-000096","form_type":"8-K","ticker":"DGX","cik":"0001022079","company_name":"QUEST DIAGNOSTICS INC","filed_at":"2024-04-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.917964+00:00","generated_at":"2026-06-03T11:12:42.890718+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Quest Diagnostics Q1 revenue $2.37B (+1.5% YoY); raises full-year adjusted EPS to $8.72-$8.97","bullets":["Revenue $2.366B, up 1.5% YoY; base business revenue grew nearly 6%.","Reported diluted EPS $1.72 (down 3.4%); adjusted diluted EPS $2.04 (flat YoY).","Full-year 2024 guidance raised: revenue $9.40B-$9.48B, adjusted EPS $8.72-$8.97.","Invigorate initiative driving productivity; growth in brain, women's, and cardiometabolic health.","Cash from operations $154M (+64.8%); capex $104M."],"urls":{"canonical":"https://secwatch.observer/filing/0001022079-24-000096","json":"https://secwatch.observer/filing/0001022079-24-000096.json","markdown":"https://secwatch.observer/filing/0001022079-24-000096.md","text":"https://secwatch.observer/filing/0001022079-24-000096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022079/000102207924000096/0001022079-24-000096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022079/000102207924000096/dgx-20240423.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T11:12:42.890718+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"25e56014605b77dcf2cf9948c1508ca8f80748a8","claim":"QUEST DIAGNOSTICS INC reported the quarter ended March 31, 2024 results: revenue $2,366, net income $194, EPS $1.72. Guidance raised.","evidence_excerpt":"adjusted earnings guidance for the full year,\" Mr. Davis said. Three Months Ended March 31, 2024 2023 Change (dollars in millions, except per share data) Reported: Net revenues $ 2,366 $ 2,331 1.5 % Diagnostic Information Services revenues $ 2,298 $ 2,259 1.7 % Revenue per requisition 0.1 % Requisition volume 1.6 % Organic requisition volume 1.0 % Operating","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1022079/000102207924000096/0001022079-24-000096-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2024"},{"label":"Revenue","value":"$2,366"},{"label":"Net income","value":"$194"},{"label":"EPS","value":"$1.72"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}